BioCentury
ARTICLE | Company News

Lidak deal

June 5, 1995 7:00 AM UTC

LDAKA will not proceed with the acquisition of Scherer Healthcare Inc.'s Biofor rational drug design subsidiary for $10 million in LDAKA common stock. LDAKA, which announced the proposed deal in mid-M...